ChM. Dr. Abdullah Al-Hadi Ahmad Fuaad, or Hadi Fuaad, is a certified chemist under the Malaysia Chemist Act 1975 and a Senior Lecturer at the Universiti Malaya. He holds a PhD in Medicinal Chemistry and a Bachelor’s degree in Biotechnology (Chemistry) from the University of Queensland, Australia. Trained across six leading research institutes in Australia, Malaysia, and the United States, including Harvard University, where he specialized in nanotoxicology. He has extensive experience in modern peptide chemistry, encompassing cyclotide synthesis, protease inhibitors, and toxin analogues. His research integrates computational design, synthesis, and characterization of bioactive peptides for the development of antiviral and vaccine candidates, as well as peptide-based carriers for drug and biopesticide delivery. By combining synthetic organic chemistry and in silico modeling, his work seeks to translate molecular design into real-world biomedical and agricultural applications. Dr. Hadi currently supervises PhD and MSc students and actively collaborates on interdisciplinary projects at the interface of chemistry, biology, and nanotechnology.   Summary: Certified chemist | PhD (Medicinal Chemistry, University of Queensland) | Expertise in peptide synthesis, click chemistry, and nanotoxicology | Research on peptide antivirals, vaccines, and carrier systems | Experienced in NMR, MALDI-MS, and peptide synthesizers | Committed educator and research mentor.

DR.-ING Nurdiana Nordin received her B.Sc. (field: Pure Chemistry) under Biasiswa Khas Tenaga Akademik (BKTA) Scholarship from the Ministry of Higher Education, Malaysia in 2012 and her M.Sc. (Field: Organic and Computational Chemistry) under SLAB Scholarship in 2015 from Universiti Malaya, Kuala Lumpur, Malaysia. After graduation, she joined the Institute of Microstructure Technology (IMT) at Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany, in 2016 under the supervision of Dr. Neil MacKinnon and Dr. Vlad Badilita in the group of Prof. Jan G. Korvink. At the same time, she also joined the Bio-Interfaces Graduate International School (BIF-IGS) at the Institut für Biologische Grenzflächen, IBG. She received her PhD degree in 2020 from BIF-IGS and the Faculty of Mechanical Engineering, KIT. In Karlsruhe, she was trained in nuclear magnetic resonance (NMR) technology and clean room fabrication of microfluidic devices. She had extensive laboratory work that included electrochemical systems, microfluidic fabrication processes, bioorganic synthesis, biopolymer surface modification, and the NMR techniques. Her research interests include NMR development, bioorganic mechanisms, biomedical microsystems (BioMEMS - sensor), organ on-a-chip, flexible electronics and metabolomic studies.

  Professor Dr Puteri Shafinaz Abdul Rahman received her tertiary education at the University of Malaya. She was awarded by the Commonwealth Scholarship and Fellowship Commission United Kingdom, a Split-site Doctorate scholarship to pursue her PhD (Proteomics) at Nottingham Trent University and the University of Malaya. She completed her PhD in 2007 and, shortly after, joined the Department of Molecular Medicine, Faculty of Medicine. Dr. Puteri is a founding member of the Universiti Malaya Centre for Proteomic Research (UMCPR), and she is currently heading the centre. She is actively involved in research and has published over 50 referred publications, with an H index of 14 (WOS). In addition, she receives numerous research grants with a cumulative total of > RM2.5 million as Principal Investigator and collaborative investigator capacity. Since 2009, 8 Masters and 8 PhDs have successfully completed their studies under her guidance. Currently, there 2 Masters and 3 PhDs under her supervision. Dr. Puteri is the Head of the Unit for Central Research Laboratories, a designated facility with state-of-the-art proteomics and genomics research equipment at the Faculty of Medicine. Considering her vast experience in research management, she has also held several administrative posts under the DVC Research & Innovation portfolio. She was appointed Deputy Dean of the Innovative Technology Research Cluster (2015-2018), Deputy Dean of Frontiers of the Natural World Research Cluster (2019-2021) and a reviewer for evaluating various grants at the national and international level. She previously held the position of the Coordinator of the Research Project Monitoring Section under the Research Management Centre Universiti Malaya (2022-2024). In terms of research, as a molecular biologist and proteomic scientist, Dr. Puteri's primary expertise is in comparative proteomics. Her team employs proteomic platforms to develop proteome profiles of biological samples. By comparing the generated proteome profiles (e.g. disease vs non-disease state, treated vs untreated, different stages or time-points), dysregulated or aberrant proteins of interest are detected and identified via mass spectrometry approaches. Using this workflow, her team has analysed profiles of sera from cancer patients with gynaecological, nasopharyngeal and bone cancers in search of potential biomarkers for the detection of cancers at an early stage. Dr. Puteri was acknowledged for her work on proteomics of gynaecological cancer when she was selected as the first prize winner of the coveted Merck Young Scientist Award in 2008. In addition to cancer biomarker studies, her team has utilised proteomics technologies for studies on natural products and herbal medicine to understand the benefits of these extracts/compounds and unravel their mechanistic basis for treating various diseases. Her team is also actively profiling proteins associated with the milk fat globule membrane (MFGM) and soluble fraction of human milk compared to other animal species. Their current project focuses on the proteome, metabolome and circadian profiles of milk from mothers in the early stages of breastfeeding babies up to 2 years of age. The aim is to investigate the interrelationship of the bioactive milk constituents and their roles in young infants' immune protection and cognitive and physical growth development.